Abstract: The present invention is related to pharmaceutical composition essentially comprising herbal extract of Chaenomelis Fructus, Achyranthis Radix, Acanthopanax, Phlomidis Radix, Gentianae Radix, Clematidis Radix, and additionally comprising herbal extract selected from group consisting of Angelicae Radix, Cnidii Rhizoma, Gastrodiae Rhizoma, Safflower, Cinnamomi Cortex, Job's tear, Aurantii nobilis Pericapium, Ledebouriellae Radix, Lonicera japonica, Akebiae caulis, Caragana chamlagu, Licorice root, Notopterygium incisum, Persicae semen, Eucommia ulmoides, Atractylodes Rhizoma, Torilis japonica according to the need for the prevention and treatment of arthritic diseases and methods of using the above extracts and composition as potent anti-inflammatory and anti-arthritic agents.
January 16, 2003
Date of Patent:
July 11, 2006
Pangenomics Co., Ltd.
Byung-Wook Cho, Mirim Jin, Hyung-Jin Jung, Sung-Seup Shin, Sunyoung Kim, Hyang Jeon, Jin-Hwan Oh, Hae-Kwan Eo, Bongcheol Kim
Abstract: The present invention relates to human Her-2/neu expressing plasmid constructs having anti-cancer activity and a DNA vaccine comprising same for preventing and/or treating cancer. The Her-2/neu DNA vaccines of the present invention can be effectively used as a therapeutic vaccine in reducing metastasis after tumor surgery or as a prophylactic vaccine for people with genetic high risk.
July 15, 2003
April 6, 2006
PANGENOMICS CO., LTD
Joon Lee, Dong-Hyeon Kim, Yeonseok Chung, Sun-Young Chang, Kyung-Chul Lee, Chang-Yuil Kang
Abstract: The present invention is related to pharmaceutical composition comprising an extract of Lentinus lepideus prepared by inventive preparation showing immune enhancing and immune modulating activity.
Abstract: The present invention is related to a crude drug composition essentially comprising herbs of Sinapis Semen Alba, Ginseng Radix, Zingiberis Rhizoma Siccus, Amomi Fructus, Myristicae Semen, Saussureae Radix, Cyperi Rhizoma, Magnoliae Cortex, Arecae Semen, Crataegi Fructus, Atractylodes Rhizoma Alba, Agastachis Herba, Glycyrrhiza Radix and additionally comprising at least one herb selected from group consisting of Polygonati Rhizoma, Artemisiae Argyi Folium, Forsythiae Fructus, Caryophylli Flos, Raphani Semen, Menthae Herba according to the need for the prevention and treatment of gastrointestinal dyskinetic diseases and methods of using the above crude drug composition and pharmaceutical composition as prokinetic agent.
April 11, 2003
October 16, 2003
Pangenomics Co., Ltd.
Byung Wook Cho, Mirim Jin, Hyung-Jin Jung, Sunyoung Kim